Fakultni nemocnice Brno; Interni kardiologicka klinika

Brno 625 00

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Primary Progressive, Ulcerative Colitis

Studies at this site

• A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis — Completed
• A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors — Completed